Mainstream

Sanuwave health targets 40%-50% Q2 revenue growth with strategic customer focus

Sanuwave health targets 40%-50% Q2 revenue growth with strategic customer focus

Post ContentsnwvRead More

You might also be interested in reading Takeda Pharmaceutical Non-GAAP EPS of ¥443.00, revenue of ¥3528.2B; raises FY outlook.

May 10, 2025
In Mainstream